Rhythm Pharmaceuticals Inc (NAS:RYTM)
$ 55.59 -0.95 (-1.68%) Market Cap: 3.47 Bil Enterprise Value: 3.14 Bil PE Ratio: 0 PB Ratio: 308.96 GF Score: 58/100

Rhythm Pharmaceuticals Inc at Bank of America Biotech SMID Cap Conference Transcript

Dec 08, 2022 / 02:40PM GMT
Release Date Price: $26.38 (-3.76%)
Operator

Ladies and gentlemen, the program is about to begin. Reminder that you can submit questions at any time via the Ask Questions tab on the webcast page. At this times, it's my pleasure to turn the program over to your hist, Tazeen Ahmad.

Tazeen Ahmad
BofA Securities, Research Division - MD in Equity Research & Research Analyst

Okay. Great. Thank you, and good morning, everybody. Thanks for continuing to participate with us at our Virtual SMID Biotech Conference. It's my pleasure to have my next presenting company with me, Rhythm Pharmaceuticals. And with me for the next 30 minutes or so is CEO, David Meeker. Good morning, David. Thanks for joining us.

David P. Meeker
Rhythm Pharmaceuticals, Inc. - Chairman, President & CEO

Good morning, Tazeen. Thank you.

Tazeen Ahmad
BofA Securities, Research Division - MD in Equity Research & Research Analyst

Well, for those who may not be as familiar with Rhythm, I thought maybe we should do a quick intro of the company.

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot